Wazza, over the past 4 weeks Fujifilm CDI have also been active in recruiting multiple positions for this facility. Have a look on LinkedIn and you'll see what I mean.
Here is an example:
https://www.linkedin.com/jobs/search/?currentJobId=1032617668&f_C=301071&locationId=OTHERS.worldwide
I wonder why the ramp up in scale? Perhaps providing stemmies for a 448 patient osteo Phase II trial might have something to do with it.
Speaking of Osteo, there is a fair bit of discussion on the RGS forum about a pending but overdue Japanese licensing deal for its Progenza adipose tissue derived MSC product for treating Osteo, which is due to start a Phase II trial. One has to wonder why CYP received funding from the NHMRC for its Phase II trial despite not having focused on this indication whereas RGS just completed a Phase I trial for this indication and is trying to get a deal done. On page 11 of RGS's recent AGM presentation, Cynata's deal with Fujifilm is quoted as an example of significant regen medicine corporate activity in Japan.
https://www.asx.com.au/asxpdf/20181122/pdf/440jyqj8l0y2hg.pdf
Interesting times ... GLTAH
Wazza, over the past 4 weeks Fujifilm CDI have also been active...
-
- There are more pages in this discussion • 1,669 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $39.74M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 22.5¢ | 22.0¢ | $15.63K | 71K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 20907 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 30000 | 2 |
View Market Depth
| Last trade - 11.55am 11/11/2024 (20 minute delay) ? |
| CYP (ASX) Chart |